CBLL
CeriBell, Inc.Healthcare · $937M market cap
Verdict
We can't put a fair value on CBLL right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow CBLL
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Sep 2, 2026: no open-market purchases, 5 sales worth $1.3M and 7 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Woo Raymond
Chief Technology Officer · 2026-09-08
Sold
$119K
Foehr David
Senior VP, Finance and PAO · 2026-09-08
Sold
$182K
Foehr David
Senior VP, Finance and PAO · 2026-09-08
Sold
$43K
Blumberg Scott
Chief Financial Officer · 2026-09-02
Sold
$16K
Chao Xingjuan
President and CEO · 2026-09-02
Sold
$973K
Other filings
Woo Raymond
Chief Technology Officer · 2026-09-08
Option exercise
$108
Woo Raymond
Chief Technology Officer · 2026-09-08
Option exercise
$18K
Woo Raymond
Chief Technology Officer · 2026-09-08
Option exercise
$19K
Foehr David
Senior VP, Finance and PAO · 2026-09-08
Option exercise
$35K
Blumberg Scott
Chief Financial Officer · 2026-09-02
Option exercise
$6K
Show all 7 other filingsShow fewer
Chao Xingjuan
President and CEO · 2026-09-02
Option exercise
$111K
Chao Xingjuan
President and CEO · 2026-09-02
Option exercise
$7K
About CeriBell, Inc.
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical…
Medical - Devices
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works